» Articles » PMID: 35535876

Purinergic Signaling Systems Across Comparative Models of Spinal Cord Injury

Overview
Date 2022 May 10
PMID 35535876
Authors
Affiliations
Soon will be listed here.
Abstract

Within the last several decades, the scientific community has made substantial progress in elucidating the complex pathophysiology underlying spinal cord injury. However, despite the many advances using conventional mammalian models, both cellular and axonal regeneration following spinal cord injury have remained out of reach. In this sense, turning to non-mammalian, regenerative species presents a unique opportunity to identify pro-regenerative cues and characterize a spinal cord microenvironment permissive to re-growth. Among the signaling pathways hypothesized to be dysregulated during spinal cord injury is the purinergic signaling system. In addition to its well-known role as energy currency in cells, ATP and its metabolites are small molecule neurotransmitters that mediate many diverse cellular processes within the central nervous system. While our understanding of the roles of the purinergic system following spinal cord injury is limited, this signaling pathway has been implicated in all injury-induced secondary processes, including cellular death, inflammation, reactive gliosis, and neural regeneration. Given that the purinergic system is also evolutionarily conserved between mammalian and non-mammalian species, comparisons of these roles may provide important insights into conditions responsible for recovery success. Here, we compare the secondary processes between key model species and the influence of purinergic signaling in each context. As our understanding of this signaling system and pro-regenerative conditions continues to evolve, so does the potential for the development of novel therapeutic interventions for spinal cord injury.

Citing Articles

Purines and purinergic receptors in primary tumors of the central nervous system.

Soares A, Dos Santos H, Domann K, Alves N, Bohm B, Haack C Purinergic Signal. 2024; .

PMID: 39352574 DOI: 10.1007/s11302-024-10053-8.


P2X7 regulates ependymo-radial glial cell proliferation in adult Danio rerio following spinal cord injury.

Stefanova E, Dychiao J, Chinn M, Borhani M, Scott A Biol Open. 2024; 13(4).

PMID: 38526172 PMC: 11033521. DOI: 10.1242/bio.060270.


Protective Effect of Hydrogen-Rich Saline on Spinal Cord Damage in Rats.

Kayabas M, Sahin L, Makav M, Alwazeer D, Aras L, Yigit S Pharmaceuticals (Basel). 2023; 16(4).

PMID: 37111284 PMC: 10143771. DOI: 10.3390/ph16040527.


From dolphins to dogs: new opportunities to understand the role of P2X4 receptors in spinal cord injury and neuropathic pain.

Sophocleous R, Sluyter R Neural Regen Res. 2022; 18(7):1497-1498.

PMID: 36571351 PMC: 10075128. DOI: 10.4103/1673-5374.360294.

References
1.
Cohen H, Briggs K, Marino J, Ravid K, Robson S, Mosser D . TLR stimulation initiates a CD39-based autoregulatory mechanism that limits macrophage inflammatory responses. Blood. 2013; 122(11):1935-45. PMC: 3772500. DOI: 10.1182/blood-2013-04-496216. View

2.
Hu B, Chen M, Huang R, Huang Y, Xu Y, Yin W . In vivo imaging of Mauthner axon regeneration, remyelination and synapses re-establishment after laser axotomy in zebrafish larvae. Exp Neurol. 2017; 300:67-73. DOI: 10.1016/j.expneurol.2017.10.028. View

3.
Bidula S, Dhuna K, Helliwell R, Stokes L . Positive allosteric modulation of P2X7 promotes apoptotic cell death over lytic cell death responses in macrophages. Cell Death Dis. 2019; 10(12):882. PMC: 6877589. DOI: 10.1038/s41419-019-2110-3. View

4.
Chorna N, Santiago-Perez L, Erb L, Seye C, Neary J, Sun G . P2Y receptors activate neuroprotective mechanisms in astrocytic cells. J Neurochem. 2004; 91(1):119-32. DOI: 10.1111/j.1471-4159.2004.02699.x. View

5.
Barry D, McDermott K . Differentiation of radial glia from radial precursor cells and transformation into astrocytes in the developing rat spinal cord. Glia. 2005; 50(3):187-97. DOI: 10.1002/glia.20166. View